← Back to Search

Other

Danuglipron for Obesity

Phase 1
Waitlist Available
Research Sponsored by Pfizer
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to understand how a medication called danuglipron is absorbed into the blood and to assess its safety and tolerability in overweight or obese healthy adults over a period of about 15 weeks

Who is the study for?
This trial is for adults who are generally healthy but have overweight or obesity issues. Participants will be involved in the study for approximately 15 weeks, which is about 4 months.
What is being tested?
The study focuses on understanding how danuglipron, a medication under investigation, behaves in the bloodstream after multiple doses over several days and assessing its safety and tolerability in participants.
What are the potential side effects?
While specific side effects of danuglipron are not detailed here, common concerns may include reactions at the dosing site, gastrointestinal symptoms, fatigue, headaches or other drug-related adverse events.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single ArmExperimental Treatment1 Intervention
Participants will receive multiple doses of danuglipron
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Danuglipron
2023
Completed Phase 1
~40

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

PfizerLead Sponsor
4,655 Previous Clinical Trials
17,746,235 Total Patients Enrolled
42 Trials studying Obesity
117,010 Patients Enrolled for Obesity
Pfizer CT.gov Call CenterStudy DirectorPfizer
3,542 Previous Clinical Trials
14,917,411 Total Patients Enrolled
31 Trials studying Obesity
120,264 Patients Enrolled for Obesity
~13 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top